Despite the higher cytotoxicity in the former that had basic expression of P-gp, SIT inhibited P-gp activity in both cell types, indicating that SIT was able to act as an effective P-gp inhibitor to target tumor cells with high MDR potential [251]. The gene discussed is PGP; the disease is neoplasm.